Notice on the 2nd Extraordinary General Meeting in 2025
Filed with SSE · · 6 pages · Chinese
Zhejiang Huakang Pharmaceutical Co., Ltd. on 6ix
Earlier from Zhejiang Huakang Pharmaceutical
- Announcement on Transferring Shares of Invested Company
- Announcement on Amendment to Report on Purchasing Assets through Issuance of Shares and Cash Payment and Related Party Transaction (Draft) (Declaration)
- Supplementary Announcement on Repurchase and Cancellation of Partial Restricted Stocks to Reduce Registered Capital and Notice to Creditors
- Announcement on Receiving Dividends from Wholly-owned Subsidiary
- Announcement on Reply to Letter of Supervision and Inquiry from Shanghai Stock Exchange on Information Disclosure of 2024 Annual Report
Later from Zhejiang Huakang Pharmaceutical
- Announcement on Returning Idle Raised Funds Temporarily Used for Supplementing Current Capital in Advance
- Announcement on Resignation of Non-independent Director and Election of Employee Representative Director
- Indicative Announcement on Stopping Conversion of "Huakang Convertible Bonds" when Implementing 2025 Interim Dividend Distribution
- Announcement on Implementation of Semi-annual Dividend Distribution for 2025
- Announcement on Convening the 2025 Semi-annual Performance Briefing
Follow Zhejiang Huakang Pharmaceutical into a list and get an email when it puts out news.
Follow Zhejiang Huakang Pharmaceutical